recombinant diphtheria toxin epidermal growth factor fusion protein (University of Colorado System)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant diphtheria toxin epidermal growth factor fusion protein (University of Colorado System)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionElongation factor 2 inhibitorsEpidermal growth factor modulators
TargetsElongation factor 2Epidermal growth factor
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Colorado SystemUniversity Of Colorado
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A